Miller Joseph M's Form 4/A amendment
AmendedAurinia Pharmaceuticals Inc. (AUPH) · filed Feb 22, 2024
- Accession no.
- 0001600620-24-000014
- Filed
- Feb 22, 2024
- Trade date
- Mar 2, 2023
- Filing delay
- 357 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 6, 2023
This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $100.1K. It was filed 357 days after the trade.
This amendment restates part of 0001628280-23-006531 (filed Mar 6, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller Joseph MCIK 0001746372 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | SSaleDisposed | −11,398 | $8.78 | −$100,074.44 | 331,112 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001628280-23-006531 (filed Mar 6, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +229,421 | –F2 | – | 342,510 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Remarks
This amendment is being filed to amend the Form 4 filed on March 6, 2023 with the SEC in order to correct the amount sold, price per share and total securities owned after the transaction.